# ELECTRA Therapeutics funding rounds and investors

As of 14 Oct 2026, ELECTRA Therapeutics has raised $183M across 1 verified round on record; latest: $183 million Series C led by EQT Life Sciences and Nextech, announced 22 Oct 2025.

Electra Therapeutics develops SIRP-directed therapies designed to improve outcomes for patients with immune-mediated diseases and cancer.

Website: https://electra-therapeutics.com  
Headquarters: South San Francisco  
Page: https://fireround.dev/companies/electra-therapeutics.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-10-22 | Series C | $183 million | EQT Life Sciences, Nextech | Blue Owl, Cormorant Asset Management, HBM Healthcare Investments, Mubadala Capital, New Leaf Ventures, OrbiMed, RA Capital Management, Redmile Group, Sanofi Ventures, Westlake BioPartners | [electra-therapeutics.com](https://electra-therapeutics.com/electra-therapeutics-announces-183-million-series-c-financing-to-advance-first-in-class-sirp-targeted-therapies-for-immune-disorders-and-cancer), [fiercebiotech.com](https://www.fiercebiotech.com/biotech/some-encouraging-signs-market-electra-shines-183m-fundraise-rare-disease-trial) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.